Multinational pharmaceutical company, MSD has renewed its commitment to strengthening healthcare access in Nigeria, calling ...

The flu season is ramping up with more cases, more hospital admissions and more patients sent to intensive care units.

WHO includes ArkBio' paediatric RSV drug, ziresovir in PADO-RSV priority list: Shanghai, China Thursday, July 17, 2025, 14:00 Hrs [IST] Shanghai Ark Biopharmaceutical Co., Ltd. (A ...

The COVID-19 pandemic exposed critical gaps in infection control across senior living communities. Despite extensive cleaning protocols, outbreaks were ...

In the newly released "Paediatric drug optimization for respiratory syncytial virus (PADO-RSV) meeting report" by Global ...

The offering, the first IPO this year, attracted more than 32 billion dirhams ($3.5 bln) in demand for 500 million dirhams in shares. GSK seeks FDA nod for expanded use of RSV vaccine in adults ...

Kennedy selected a new team of medical professionals and scientists who are highly qualified and dedicated to public health.

Testing at India’s National Institute of Virology has confirmed a third recent Nipah virus case from India’s Kerla state, ...

The disease was found following tests on a severely emaciated doe that was euthanized and tested in early June, Andrea Korman ...

With the 2025 influenza season starting earlier than usual, the NICD urges South Africans to stay vigilant against seasonal ...

Respiratory Syncytial Virus (RSV) is a major cause of acute respiratory tract infections (ARTIs) and can trigger outbreaks in vulnerable settings such as nursing homes, pediatric wards, and neonatal ...

RSV is causing thousands of infant deaths in India yearly, yet remains underdiagnosed. Experts stress the urgent need for ...